BSGM (BioSig Technologies) חוב לטווח קצר להון

Biosig Technologies (BSGM) efficiency relies on the seamless transport of high-tech mapping systems to medical centers. Unique patents for ECG analysis software and strict FDA compliance provide business protection. The current market quotes visualized below with the 0.00 indicator are supplemented by adherence to environmental standards for electronic component disposal and energy efficiency in production.

This indicator compares liabilities with maturities of up to one year against total equity to identify cash gaps and assess solvency. For Biosig Technologies (BSGM), which is developing the high-precision PUREEP system for cardiac surgery, the short-term debt-to-equity ratio reflects the balance between debt-funded innovation and financial stability, where any sharp spike in the curve signals an increase in fundamental business risks.